
### [MONDO:0002887](http://purl.obolibrary.org/obo/MONDO_0002887)
**Label:** bile duct disease

**Subclasses:** [MONDO:0018646](http://purl.obolibrary.org/obo/MONDO_0018646) (sclerosing cholangitis (disease)), [MONDO:0015762](http://purl.obolibrary.org/obo/MONDO_0015762) (progressive familial intrahepatic cholestasis), [MONDO:0013433](http://purl.obolibrary.org/obo/MONDO_0013433) (primary sclerosing cholangitis), [MONDO:0019008](http://purl.obolibrary.org/obo/MONDO_0019008) (benign recurrent intrahepatic cholestasis), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), [MONDO:0011559](http://purl.obolibrary.org/obo/MONDO_0011559) (benign recurrent intrahepatic cholestasis type 2), [MONDO:0019072](http://purl.obolibrary.org/obo/MONDO_0019072) (intrahepatic cholestasis), [MONDO:0017590](http://purl.obolibrary.org/obo/MONDO_0017590) (carcinoma of the ampulla of vater), 

**Corr. equiv. classes:** [Orphanet:447771](http://www.orpha.net/ORDO/Orphanet_447771), [Orphanet:172](http://www.orpha.net/ORDO/Orphanet_172), [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:300557](http://www.orpha.net/ORDO/Orphanet_300557), [OMIM:605479](http://purl.obolibrary.org/obo/OMIM_605479), [Orphanet:171](http://www.orpha.net/ORDO/Orphanet_171), [Orphanet:69665](http://www.orpha.net/ORDO/Orphanet_69665), [Orphanet:99961](http://www.orpha.net/ORDO/Orphanet_99961), [Orphanet:65682](http://www.orpha.net/ORDO/Orphanet_65682), [OMIM:613806](http://purl.obolibrary.org/obo/OMIM_613806), 

**Class expressions from DL-Learner:**

- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) 65.00%
- [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) and [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) and [HP:0001396](http://purl.obolibrary.org/obo/HP_0001396) (Cholestasis) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%
- [HP:0000989](http://purl.obolibrary.org/obo/HP_0000989) (Pruritus) and [HP:0001005](http://purl.obolibrary.org/obo/HP_0001005) (Dermatological manifestations of systemic disorders) and [HP:0001081](http://purl.obolibrary.org/obo/HP_0001081) (Cholelithiasis) 65.00%
- [HP:0000952](http://purl.obolibrary.org/obo/HP_0000952) (Jaundice) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012437](http://purl.obolibrary.org/obo/HP_0012437) (Abnormal gallbladder morphology) 65.00%


